NASDAQ:CTNM | Cash Flow Statement | Contineum Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$15.15M
2026-03-31-$14.46M$83,000.00-$16.27M$312,000.00-$39.31M$129,000.00
2025-12-31-$15.16M$85,000.00-$13.04M$42,000.00-$47.45M$93.47M
2025-09-30-$12.79M
2025-06-30-$16.04M
2025-03-31-$15.99M$78,000.00-$14.41M$47,000.00$14.92M$24,000.00
2024-12-31-$14.57M$75,000.00-$10.2M$166,000.00-$9.39M$642,000.00
2024-09-30-$10.27M
2024-06-30-$9.01M
2024-03-31-$8.42M$61,000.00-$7.98M$147,000.00$8.73M-$18,000.00
2023-12-31-$7.77M$37,000.00-$10.7M$309,000.00$9.03M-$321,000.00
2023-09-30-$6.25M
2023-06-30$41.56M
2023-03-31-$4.82M$73,000.00-$5.24M$52,000.00$9.36M-$617,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$59.98M$323,000.00-$55.31M$231,000.00-$3.71M$112.69M
2024-12-31-$42.26M$258,000.00-$32.85M$514,000.00-$69.74M$109M
2023-12-31$22.72M$195,000.00$19.35M$414,000.00-$65.57M$56.18M